CAD 0.03
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 11.77 Million CAD | 16.94% |
2022 | 10.07 Million CAD | 177.23% |
2021 | 3.63 Million CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 3.33 Million CAD | 11.59% |
2024 Q3 | 3.32 Million CAD | -0.23% |
2024 Q1 | 2.98 Million CAD | 5.21% |
2023 Q3 | 3.54 Million CAD | 1.99% |
2023 FY | 11.77 Million CAD | 16.94% |
2023 Q1 | 1.91 Million CAD | -39.85% |
2023 Q2 | 3.47 Million CAD | 81.35% |
2023 Q4 | 2.84 Million CAD | -19.9% |
2022 Q4 | 3.18 Million CAD | 9.44% |
2022 Q3 | 2.91 Million CAD | 25.47% |
2022 FY | 10.07 Million CAD | 177.23% |
2022 Q2 | 2.32 Million CAD | 40.43% |
2022 Q1 | 1.65 Million CAD | -19.91% |
2021 Q4 | 2.06 Million CAD | 59.88% |
2021 FY | 3.63 Million CAD | 0.0% |
2021 Q3 | 1.29 Million CAD | 495.52% |
2021 Q1 | 62.42 Thousand CAD | 0.0% |
2021 Q2 | 216.73 Thousand CAD | 247.22% |
2020 Q3 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aion Therapeutic Inc. | 367.47 Thousand CAD | -3105.54% |
Ayurcann Holdings Corp. | 25.15 Million CAD | 53.176% |
Blueberries Medical Corp. | 288.27 Thousand CAD | -3986.31% |
The BC Bud Corporation | 61.48 Thousand CAD | -19059.572% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -3064.482% |
CordovaCann Corp. | 13.59 Million CAD | 13.351% |
Captor Capital Corp. | 36.76 Million CAD | 67.96% |
City View Green Holdings Inc. | 8582.00 CAD | -137160.405% |
1CM Inc. | 35.34 Million CAD | 66.669% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -125.225% |
IM Cannabis Corp. | 48.8 Million CAD | 75.863% |
Lobe Sciences Ltd. | 840.53 Thousand CAD | -1301.453% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -19532.813% |
Nextleaf Solutions Ltd. | 8.17 Million CAD | -44.013% |
Ovation Science Inc. | 61.93 Thousand CAD | -18919.744% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -6639.453% |
RAMM Pharma Corp. | 5.06 Million CAD | -132.558% |
RIV Capital Inc. | 7.48 Million CAD | -57.313% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 88.33 Million CAD | 86.664% |
SLANG Worldwide Inc. | 35.68 Million CAD | 66.987% |
1933 Industries Inc. | 18.27 Million CAD | 35.536% |
Red Light Holland Corp. | 4.75 Million CAD | -147.89% |
Top Strike Resources Corp. | 13.32 Million CAD | 11.613% |
Xebra Brands Ltd. | 106.85 Thousand CAD | -10923.993% |
Adastra Holdings Ltd. | 22.22 Million CAD | 46.992% |